Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
The new online Learning Center with new content can still be found under the “Training” folder on ...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...